Clinical Trials

620 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07509151 2026-04-03

SOUNDTRACK-C1

420 enrolled

Leukemia, Lymphoma, Leukemia, B-Cell

NCT07407140 2026-03-25

VAG-3+7-G

300 enrolled

Leukemia, Myeloid, Acute

NCT07489755 2026-03-24

TGRX-678 Chinese Phase III in Chronic Myelogenous Leukemia (CML) Patients

MyeloidOther hematologic neoplasm

180 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT07486479 2026-03-20

Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML

204 enrolled

Leukemia, Myeloid, Acute

NCT07478991 2026-03-18

VENP-A-QUI

376 enrolled

Leukemia, Myeloid, Acute

NCT07223190 2026-03-04

AUDAX

560 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07022678 2026-02-27

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

556 enrolled

Leukemia, Myeloid, Acute

NCT07407660 2026-02-12

Shortened Venetoclax Duration Based on Day 14 BM Blasts Versus Standard Therapy in Elderly or Frail Patients With AML Patients Treated With Azacitidine Plus Venetoclax

250 enrolled

Leukemia, Myeloid, Acute

NCT07342478 2026-01-16

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

306 enrolled

Chromosome 17 deletion, Recurrence, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07321652 2026-01-07

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

466 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT07296445 2025-12-29

LATITUDE

120 enrolled

Leukemia, Leukemia, Promyelocytic, Acute

NCT07082452 2025-07-24

SEVENAZA

262 enrolled

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT06673459 2024-11-05

BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients

430 enrolled

Leukemia, T-Cell

NCT06613035 2024-09-25

Twice-per-weekSelinexor, 2 Days Melphalan

126 enrolled

Leukemia, Myeloid, Acute

NCT06297772 2024-06-04

Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR

220 enrolled

Leukemia, Myeloid, Acute

NCT06434467 2024-05-30

The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma

83 enrolled

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06278896 2024-02-26

END

Classical hematologyOther hematologic neoplasm

260 enrolled

Hematologic Neoplasms, Febrile Neutropenia

NCT06182592 2023-12-28

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

120 enrolled